Remove 2010 Remove Community Remove Patients Remove Provider
article thumbnail

Access to health care and services for the Deaf: A scoping review of reviews [Health care services, delivery, and financing]

Annals of Family Medicine

A growing number of research has been published on the subject, but the Deaf community remains underserved in health care and under-represented in health research. 2010) and adapted by Schultz et al. A patient partner from the Deaf community collaborated on each step of this project. Population Studied: Deaf adults.

Finance 130
article thumbnail

How Locum Tenens Fits Into Modern Healthcare Staffing Solutions

Barton Associates

There’s a lot that goes into running a healthcare facility , from managing patient care to ensuring adequate coverage around the clock. In these complex and ever-changing environments, staffing challenges can quickly become a critical issue, impacting both patient care quality and operational efficiency.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

My Green Doctor Begins Pilot with Weill Cornell Medicine

My Green Doctor

With a network of over 1,300 physicians and 40+ patient care locations across New York City, Weill Cornell’s influence in healthcare delivery and education is far-reaching. 19 countries have national medical associations that provide MGD resources. 19 countries have national medical associations that provide MGD resources.

article thumbnail

Overtreatment of prostate cancer in the active surveillance era

Common Sense Family Doctor

Active surveillance is a management strategy that is intended to limit overtreatment of localized prostate cancer by monitoring patients with periodic PSA measurements and prostate biopsies to delay or avoid curative therapy (radical prostatectomy or radiation therapy) and its adverse effects. and 6.1%, respectively). in 2000 to 59.8%

article thumbnail

A Historic Day in Drug Development: FDA Approves Amylyx’s Drug to Treat ALS, Demonstrating FDA’s Application of Appropriate Flexibility in Rare Diseases

FDA Law

Valentine — On September 29, 2022, FDA approved Amylyx’s NDA for its drug, Relyvrio (sodium phenylbutyrate/taurursodiol), for treatment of patients with amyotrophic lateral sclerosis (ALS) (see FDA announcement here ). This is evidence of FDA’s embrace of patient-focused drug development. By Frank J. Sasinowski & James E.

article thumbnail

Green Practice News: May 2025

My Green Doctor

This isn’t just about saving the planet—it’s also about saving money, protecting patients, and strengthening our healthcare systems from the inside out. The breadth of services provided by modern day medicine is profound. Dilating and anesthetic eye drops are routinely offered to patients in most ophthalmology clinics.

article thumbnail

Transforming the Culture of Dementia Care: Podcast with Anne Basting, Ab Desai, Susan McFadden, and Judy Long

GeriPal

Her most recent book is Dementia Friendly Communities: why we need them and how we can create them . She directs UCSF MERI’s patient, family, and clinician support with classes and consultation on resiliency, well-being, and grief. When was that, 2010? Eric: 2010. Transcript. Eric: Welcome to the GeriPal podcast.

Community 102